CA
LABU icon

Calton & Associates’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Calton & Associates’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-21
Closed -$45K – 867
2017
Q4 		$45K Buy
+21
New +$32.1K 0.01% 709

Other funds holding LABU

HJMC
Hellman Jordan Management Company Quincy, Massachusetts $58.9M AUM 18.56% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
EWA
Exencial Wealth Advisors Oklahoma City, Oklahoma $3.22B AUM 20.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return

Calton & Associates's LABU Position: Q1 2018 in Review

Calton & Associates sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q1 2018, closing a stake of 21 shares — an estimated $45K sold.

Calton & Associates first reported a position in LABU in Q4 2017 and held it in 1 quarter. The position peaked at $45K in Q4 2017. 13 funds tracked by Wall St. Rank hold LABU as of Q1 2018.

  • Calton & Associates reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q1 2018 after selling out during the quarter.
  • Calton & Associates sold 21 Direxion Daily S&P Biotech Bull 3X ETF shares in Q1 2018, an estimated $45K.
  • Calton & Associates first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q4 2017 and held it in 1 quarter.
  • Calton & Associates's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $45K in Q4 2017.
  • 13 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q1 2018.

Based on Calton & Associates's 13F filing for Q1 2018, filed 17 Apr 2018.